作者: Koenraad K. Norga
DOI: 10.1007/S00431-010-1389-Y
关键词:
摘要: Since its establishment as a pediatric subspecialty oncology has become the near exclusive domain of specialized tertiary centers. This greatly aided progress in field with formation exemplary and highly focused international consortia that have continued to streamline clinical research efforts. Recently, rate terms further improvements overall outcome paradoxically slowed. Novel strategies are therefore needed assure advances. On one hand, global subspecialists will continue focus on development much improved therapies for those disease groups not yet seen their prognosis brighten, other there is trend invest joint-care initiatives cost-effective access standard therapy all. require closer involvement general pediatrician certain aspects cancer care broadest sense. We hope upcoming series aid this process by highlighting selected topics likely gain even more relevance years come. They include: screening predisposition syndromes; molecular diagnosis risk-adjustment acute leukemia childhood; an overview new agents development; impact treatment fertility available preservation options.